// App-Quantinova.ai

TCT-19 : The Impact of Coronary Lesion Severity on Drug-eluting Stent Outcomes in Patients with and without Diabetes Mellitus

Researchers

Presenter

  • Elvin Kedhi

Principal Investigators

  • Philippe Genereux

  • Tullio Palmerini

  • Tom McAndrew

  • Helen Parise

  • George Dangas

  • Roxana Mehran

  • Ori Ben-Yehuda

  • Gregg Stone

Medical Centers

  • Mount Sinai, New York, New York, NY

  • Mount Sinai Hospital, New York, NY

  • Cardiovascular Research Foundation, New York, United States

  • Cardiovascular Research Foundation, Orangeburg, NY

  • Isala Clinics, Zwolle, Netherlands

  • Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY

  • Policlinico S. Orsola Malphigi, Bologna, Italy

Locations

  • United States

  • Italy

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Myocardial infarction

  • Diabetes

  • Venous thrombosis

  • Restenosis

Biomarkers

  • Acetyl-CoA carboxylase

Drug/Treatment

  • ZoMaxx

  • TAXUS

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved